Microsoft's Health Tech Push Opens New Investment Avenues

By Kirsteen Mackay


In this article

  • Loading...
  • Want to see what you should be buying? Check out our top picks.

Microsoft's new healthcare tools could revolutionize the sector. Learn how these changes offer fresh investment opportunities in tech and healthcare stocks.

Magnifying glass over white cross depicting zooming in on healthcare sector.
Growth or Value? Microsoft Offers Both in Healthcare

TL: DR - What You Need To Know

Microsoft (NASDAQ: MSFT) has stepped up its game in the health-care sector by launching specialized data and AI tools aimed at helping medical organizations make sense of vast amounts of fragmented data.

Announced at the HLTH conference in Las Vegas, these new tools are part of Fabric, Microsoft's data and analytics platform. One of the key features of this platform is its ability to consolidate data from multiple sources like electronic health records, medical images, and lab systems into one accessible location. This helps health-care providers save time by not having to manually sift through multiple databases.

The health care industry accounts for a massive 30% of all data generated globally, but nearly 97% of hospital data remains untapped. Microsoft's new offerings aim to tackle this inefficiency head-on. Initial trials have been carried out with notable institutions like Northwestern Medicine and SingHealth. The Chief Information Officer at Northwestern Medicine even foresees these new tools as potential game changers, particularly when integrated for future applications such as patient flow management and staffing.

Microsoft didn't stop there. It also unveiled AI tools within its Azure services, including a generative AI chatbot called Azure AI Health Bot. This chatbot can assist both staff and patients by pulling information from internal databases as well as external authoritative sources like the FDA.

Additional tools like Text Analytics for health and Azure AI Health Insights aim to further streamline clinicians' workflow and improve patient care.

These new services are now available for preview and stand to revolutionize the way health care providers handle data and patient management.

Why This Is Important for Retail Investors

  1. Investment Opportunity in Health Tech: The announcement from Microsoft signals an aggressive push into the health tech sector. For retail investors, this offers a clear opportunity to invest in a segment that is ripe for disruption and innovation. Companies involved in medical data and AI, including Microsoft, could see significant revenue growth and valuation uplift.

  2. Risk Mitigation: Microsoft's advancements in data consolidation and AI in healthcare could make the sector more efficient and potentially more profitable. For retail investors, this adds a layer of risk mitigation when considering investments in health-care stocks, particularly those that collaborate with or use Microsoft's new technology.

  3. Industry Benchmarking: Microsoft's entry sets a precedent that other tech giants may follow, affecting market dynamics. A trend set by a tech giant like Microsoft often serves as a benchmark, driving up industry standards and, subsequently, stock prices.

  4. Enhanced Decision-Making: The data analytics and AI capabilities in health care can be a treasure trove of actionable insights. Retail investors who understand these technologies can better assess the viability, future growth, and competitive advantages of companies in the health-care sector, thus making more informed investment decisions.

  5. Early Adoption Advantage: Retail investors who recognize the transformative potential of these technologies may gain an early adopter advantage.

Sign up for Investing Intel Newsletter

How Can You Use This Information?

Here are some of the investing ideas that can be explored using this information:

Growth Investing

  • Given Microsoft's expansion into the health-care sector, the company itself could be an attractive target for growth investors. Its Fabric and Azure AI platforms have significant potential to disrupt the health-care industry. Other companies collaborating with Microsoft on these projects can also be good growth prospects.

Value Investing

  • Investors can look for health-care companies that are undervalued but have the potential to significantly benefit from Microsoft's technology. The adoption of these technologies could unlock new revenue streams and improve operational efficiency, eventually leading to a revaluation of the stock.

Momentum Investing

  • Watch for health-care or tech stocks that start showing a strong uptrend following the adoption or roll-out of Microsoft's new technologies. The news and subsequent developments can create market momentum that traders can capitalize on.

Sector Rotation

  • With Microsoft's entry, technology is further encroaching into health care. Investors might consider reducing exposure to traditional health-care stocks in favor of tech companies making inroads in this sector.


  • As Microsoft partners with various health-care institutions, investors may consider diversifying their portfolio by including a mix of tech and health-care stocks. This approach could provide both sectoral balance and exposure to a thematic trend of tech-driven health-care innovation.

ETFs and Mutual Funds

  • For those who want to capture the trend without picking individual stocks, there are specialized ETFs and mutual funds focused on health technology. These funds provide a way to invest in a basket of companies poised to benefit from advancements in data analytics and AI in healthcare.

Long-Term Investment

  • Microsoft’s push into healthcare is a long-term strategic move. Investors looking for long-term holdings might consider adding companies that are expected to collaborate with Microsoft's health-care technologies to their portfolios.

Read What Others Are Saying

What you should read next:

Explore more on these topics:



This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.

Kirsteen Mackay does not hold any position in the stock(s) and/or financial instrument(s) mentioned in the above article.

Kirsteen Mackay has not been paid to produce this piece by the company or companies mentioned above.

Digitonic Ltd, the owner of, does not hold a position or positions in the stock(s) and/or financial instrument(s) mentioned in the above article.

Digitonic Ltd, the owner of, has not been paid for the production of this piece by the company or companies mentioned above.

Sign up for Investing Intel Newsletter